Qube Research & Technologies (QRT)’s MediciNova MNOV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-32	Closed	-$46	–	3810
2024 Q2	$46	Sell	32 -1,049	-97%	-$1.47K	﹤0.01%	3508
2024 Q1	$1.57K	Sell	1,081 -1,633	-60%	-$2.32K	﹤0.01%	4012
2023 Q4	$4.07K	Buy	2,714 +2,682	+8,381%	+$4.85K	﹤0.01%	3747
2023 Q3	$67	Buy	+32	New	+$74	﹤0.01%	3793
2023 Q1	–	Sell	-10,440	Closed	-$21.4K	–	2848
2022 Q4	$21.4K	Sell	10,440 -24,626	-70%	-$54.4K	﹤0.01%	2224
2022 Q3	$76K	Buy	35,066 +9,760	+39%	+$22.6K	﹤0.01%	2052
2022 Q2	$64K	Buy	+25,306	New	+$66K	﹤0.01%	2071
2022 Q1	–	Sell	-13,797	Closed	-$37K	–	2790
2021 Q4	$37K	Buy	+13,797	New	+$46.1K	﹤0.01%	2305

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MNOV Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of MediciNova (MNOV) in Q3 2024, closing a stake of 32 shares — an estimated $46 sold.

Qube Research & Technologies (QRT) first reported a position in MNOV in Q4 2021 and held it in 8 quarters. The position peaked at $76K in Q3 2022. 30 funds tracked by Wall St. Rank hold MNOV as of Q3 2024.

Qube Research & Technologies (QRT) reported no remaining MediciNova position as of Q3 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 32 MediciNova shares in Q3 2024, an estimated $46.
Qube Research & Technologies (QRT) first reported a position in MediciNova in Q4 2021 and held it in 8 quarters.
Qube Research & Technologies (QRT)'s MediciNova position peaked at $76K in Q3 2022.
30 funds tracked by Wall St. Rank held MediciNova as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.